EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammatory Network Architecture Across Bone Marrow Failure: An Immune-Genetic Continuum

Swarna Beesetti

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl50689 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Swarna Beesetti. Beteiligte Einrichtung: Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: Inflammation, Bone Marrow Diseases. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone marrow failure (BMF) syndromes encompass inherited disorders, immune-mediated aplasia, and clonal myeloid neoplasms, which share overlapping biology but divergent clinical trajectories. Inflammation shapes hematopoietic stem and progenitor cell fate across this spectrum, yet its network organization, genetic conditioning, and therapeutic implications remain incompletely defined. An integrative, literature-based analysis of inflammatory cytokines, genetic contexts, and therapeutic targeting across major BMF disorders, including inherited BMF syndromes, aplastic anemia (AA), myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), and myelofibrosis (MF). Gene–inflammation–outcome networks and co-occurrence maps were constructed with stratification by germline and somatic alterations. Therapeutic activity was mapped across cytokine-directed and pathway-targeted agents. Inflammatory signaling emerged as a conserved feature across all BMF categories, with TNF-α, IFN-γ, and IL-6 forming a recurrent core module, and TGF-β linking inflammatory programs to fibrotic remodeling. TP53- and JAK2-associated pathways appeared as central nodes integrating multi-cytokine inputs. Germline lesions in FANCA, TERC/TERT, and GATA2 were predominantly associated with apoptotic stem-cell attrition. In contrast, somatic drivers, including TP53, JAK2, TET2, DNMT3A, and ASXL1, were more frequently associated with clonal expansion. Multi-cytokine convergence on shared effectors was common, suggesting pathway redundancy. The therapeutic literature predominantly focused on TNF-α/IFN-γ/IL-6 pathways, with comparatively limited exploration of TGF-β, IL-8, and IL-17. These findings support a role for inflammation as a unifying, context-dependent modifier across the BMF spectrum, and highlight TP53- and JAK2-centered circuitry as potential nodes for rational combination strategies. TGF-β, IL-8, and IL-17 axes and inherited BMF entities represent underexplored opportunities for biomarker-guided cytokine-directed intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationBone Marrow DiseasesHumansCytokinesSignal TransductionMyelodysplastic SyndromesJanus Kinase 2Myeloproliferative DisordersPrimary MyelofibrosisBone Marrow Failure DisordersAnemia, Aplastic

Stichwörter der Autor:innen

IL-6TGF-βTNF-αbone marrow failurecytokinesgermline mutationsinflammationinterferon-gammamyelodysplastic syndromemyelofibrosismyeloproliferative neoplasmsomatic mutations

Substanzen

CytokinesJanus Kinase 2

Autor:innen und Institutionen

  • Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Zitieren

APA

Beesetti, S. (2026). Inflammatory Network Architecture Across Bone Marrow Failure: An Immune-Genetic Continuum. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl50689

Vancouver

Beesetti S. Inflammatory Network Architecture Across Bone Marrow Failure: An Immune-Genetic Continuum. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl50689

BibTeX
@article{Beesetti2026,
  author = {Beesetti, Swarna},
  title = {Inflammatory Network Architecture Across Bone Marrow Failure: An Immune-Genetic Continuum},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl50689}
}
Kostenlos starten →